We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to MAPK8

GAST — MAPK8

Text-mined interactions from Literome

Dehez et al., FEBS Lett 2001 : We present evidence that gastrin , binding to a G protein coupled receptor, activates the p38-mitogen activated protein kinase ( MAPK ) pathway
Schmitz et al., Eur J Clin Invest 2001 (Colorectal Neoplasms) : Mutation 287V -- > F is associated with a loss of gastrin induced MAPK p44/p42 signalling in Colo 320 cells while clonal expansion from single cells is increased by 53.1 +/- 15.9 % when compared to Colo 320 cells expressing wild-type CCK-B/gastrin receptors
Tucker et al., Helicobacter 2010 (Disease Models, Animal...) : Activation of gastrin through MAPK signaling did not require CagA or VacA virulence factors
Todisco et al., J Biol Chem 1995 : In similar fashion, gastrin stimulated the activity of mitogen activated protein kinase , an enzyme known to mediate the induction of the c-fos serum response element in response to growth factor stimulation
Seva et al., Biochem Biophys Res Commun 1997 (Pancreatic Neoplasms) : In addition, blocking PI-3-kinase activity by wortmannin partially decreased gastrin induced MAPK activation ( 42 % +/- 3 ) as well as the tyrosine phosphorylation of She ( 50 % +/- 6 ), an upstream regulator of the Ras dependent MAPK pathway ... These results indicate that at least two signaling pathways lead to MAPK activation by gastrin , only one of which is sensitive to PI-3-kinase inhibitors